Short answer
HAEMONETICS CORP (HAE) filed an 8-K current report with the SEC on June 5, 2026 reporting Item 7.01 (Regulation FD Disclosure). Plasma and Blood Center segments combined into Apheresis beginning Q1 fiscal 2027.
HAEMONETICS CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Plasma and Blood Center segments combined into Apheresis beginning Q1 fiscal 2027
- Hospital segment renamed MedSurg to better reflect underlying markets and technologies
- Historical quarterly reconciliations available from Q1 fiscal 2024 through Q4 fiscal 2026
- Fiscal 2027 guidance recast under new segments but not reaffirmed or updated
- Potential guidance changes deferred to Q1 fiscal 2027 earnings call
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other HAEMONETICS CORP 8-K filings
Get the next HAE 8-K as it lands
Follow HAE for push alerts, or ask the research agent what this filing means.